147 related articles for article (PubMed ID: 28583116)
1. Association between total-Tau and brain atrophy one year after first-ever stroke.
Ihle-Hansen H; Hagberg G; Fure B; Thommessen B; Fagerland MW; Øksengård AR; Engedal K; Selnes P
BMC Neurol; 2017 Jun; 17(1):107. PubMed ID: 28583116
[TBL] [Abstract][Full Text] [Related]
2. No evidence for amyloid pathology as a key mediator of neurodegeneration post-stroke - a seven-year follow-up study.
Hagberg G; Ihle-Hansen H; Fure B; Thommessen B; Ihle-Hansen H; Øksengård AR; Beyer MK; Wyller TB; Müller EG; Pendlebury ST; Selnes P
BMC Neurol; 2020 May; 20(1):174. PubMed ID: 32384876
[TBL] [Abstract][Full Text] [Related]
3. Association between cerebrospinal fluid tau and brain atrophy is not related to clinical severity in the Alzheimer's disease continuum.
Solé-Padullés C; Lladó A; Bartrés-Faz D; Fortea J; Sánchez-Valle R; Bosch B; Antonell A; Molinuevo JL; Rami L
Psychiatry Res; 2011 Jun; 192(3):140-6. PubMed ID: 21546220
[TBL] [Abstract][Full Text] [Related]
4. Progressive medial temporal lobe atrophy during preclinical Alzheimer's disease.
Pettigrew C; Soldan A; Sloane K; Cai Q; Wang J; Wang MC; Moghekar A; Miller MI; Albert M;
Neuroimage Clin; 2017; 16():439-446. PubMed ID: 28879085
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal Fluid Markers of Neurodegeneration and Rates of Brain Atrophy in Early Alzheimer Disease.
Tarawneh R; Head D; Allison S; Buckles V; Fagan AM; Ladenson JH; Morris JC; Holtzman DM
JAMA Neurol; 2015 Jun; 72(6):656-65. PubMed ID: 25867677
[TBL] [Abstract][Full Text] [Related]
6. Association between cerebrospinal fluid and plasma neurodegeneration biomarkers with brain atrophy in Alzheimer's disease.
Pereira JB; Westman E; Hansson O;
Neurobiol Aging; 2017 Oct; 58():14-29. PubMed ID: 28692877
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer's Disease-Associated Cerebrospinal Fluid (CSF) Biomarkers do not Correlate with CSF Volumes or CSF Production Rate.
Edsbagge M; Andreasson U; Ambarki K; Wikkelsø C; Eklund A; Blennow K; Zetterberg H; Tullberg M
J Alzheimers Dis; 2017; 58(3):821-828. PubMed ID: 28505972
[TBL] [Abstract][Full Text] [Related]
8. Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes.
van Waalwijk van Doorn LJ; Gispert JD; Kuiperij HB; Claassen JA; Arighi A; Baldeiras I; Blennow K; Bozzali M; Castelo-Branco M; Cavedo E; Emek-Savaş DD; Eren E; Eusebi P; Farotti L; Fenoglio C; Ormaechea JF; Freund-Levi Y; Frisoni GB; Galimberti D; Genc S; Greco V; Hampel H; Herukka SK; Liu Y; Lladó A; Lleó A; Nobili FM; Oguz KK; Parnetti L; Pereira J; Picco A; Pikkarainen M; de Oliveira CR; Saka E; Salvadori N; Sanchez-Valle R; Santana I; Scarpini E; Scheltens P; Soininen H; Tarducci R; Teunissen C; Tsolaki M; Urbani A; Vilaplana E; Visser PJ; Wallin AK; Yener G; Molinuevo JL; Meulenbroek O; Verbeek MM
J Alzheimers Dis; 2017; 56(2):543-555. PubMed ID: 28059783
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid levels of neurofilament and tau correlate with brain atrophy in natalizumab-treated multiple sclerosis.
Mellergård J; Tisell A; Blystad I; Grönqvist A; Blennow K; Olsson B; Dahle C; Vrethem M; Lundberg P; Ernerudh J
Eur J Neurol; 2017 Jan; 24(1):112-121. PubMed ID: 27699930
[TBL] [Abstract][Full Text] [Related]
10. Whole-brain atrophy rate and CSF biomarker levels in MCI and AD: a longitudinal study.
Sluimer JD; Bouwman FH; Vrenken H; Blankenstein MA; Barkhof F; van der Flier WM; Scheltens P
Neurobiol Aging; 2010 May; 31(5):758-64. PubMed ID: 18692273
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of CSF and MRI biomarkers for detecting preclinical Alzheimer's disease.
Schmand B; Huizenga HM; van Gool WA
Psychol Med; 2010 Jan; 40(1):135-45. PubMed ID: 19863841
[TBL] [Abstract][Full Text] [Related]
12. Plasma Tau Association with Brain Atrophy in Mild Cognitive Impairment and Alzheimer's Disease.
Deters KD; Risacher SL; Kim S; Nho K; West JD; Blennow K; Zetterberg H; Shaw LM; Trojanowski JQ; Weiner MW; Saykin AJ;
J Alzheimers Dis; 2017; 58(4):1245-1254. PubMed ID: 28550246
[TBL] [Abstract][Full Text] [Related]
13. Alzheimer's Disease Biomarkers and Future Decline in Cognitive Normal Older Adults.
Dumurgier J; Hanseeuw BJ; Hatling FB; Judge KA; Schultz AP; Chhatwal JP; Blacker D; Sperling RA; Johnson KA; Hyman BT; Gómez-Isla T
J Alzheimers Dis; 2017; 60(4):1451-1459. PubMed ID: 29036824
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid biomarkers and cerebral atrophy in distinct clinical variants of probable Alzheimer's disease.
Ossenkoppele R; Mattsson N; Teunissen CE; Barkhof F; Pijnenburg Y; Scheltens P; van der Flier WM; Rabinovici GD
Neurobiol Aging; 2015 Aug; 36(8):2340-7. PubMed ID: 25990306
[TBL] [Abstract][Full Text] [Related]
15. Brain metabolic correlates of CSF Tau protein in a large cohort of Alzheimer's disease patients: A CSF and FDG PET study.
Chiaravalloti A; Barbagallo G; Ricci M; Martorana A; Ursini F; Sannino P; Karalis G; Schillaci O
Brain Res; 2018 Jan; 1678():116-122. PubMed ID: 29066367
[TBL] [Abstract][Full Text] [Related]
16. CSF tau markers are correlated with hippocampal volume in Alzheimer's disease.
de Souza LC; Chupin M; Lamari F; Jardel C; Leclercq D; Colliot O; Lehéricy S; Dubois B; Sarazin M
Neurobiol Aging; 2012 Jul; 33(7):1253-7. PubMed ID: 21489655
[TBL] [Abstract][Full Text] [Related]
17. Cognitive impairment in HIV infection is associated with MRI and CSF pattern of neurodegeneration.
Steinbrink F; Evers S; Buerke B; Young P; Arendt G; Koutsilieri E; Reichelt D; Lohmann H; Husstedt IW;
Eur J Neurol; 2013 Mar; 20(3):420-428. PubMed ID: 23095123
[TBL] [Abstract][Full Text] [Related]
18. Neurogranin and tau in cerebrospinal fluid and plasma of patients with acute ischemic stroke.
De Vos A; Bjerke M; Brouns R; De Roeck N; Jacobs D; Van den Abbeele L; Guldolf K; Zetterberg H; Blennow K; Engelborghs S; Vanmechelen E
BMC Neurol; 2017 Aug; 17(1):170. PubMed ID: 28854881
[TBL] [Abstract][Full Text] [Related]
19. Association of Cerebrospinal Fluid (CSF) Insulin with Cognitive Performance and CSF Biomarkers of Alzheimer's Disease.
Geijselaers SLC; Aalten P; Ramakers IHGB; De Deyn PP; Heijboer AC; Koek HL; OldeRikkert MGM; Papma JM; Reesink FE; Smits LL; Stehouwer CDA; Teunissen CE; Verhey FRJ; van der Flier WM; Biessels GJ;
J Alzheimers Dis; 2018; 61(1):309-320. PubMed ID: 29154275
[TBL] [Abstract][Full Text] [Related]
20. Visual Ratings of Medial Temporal Lobe Atrophy Correlate with CSF Tau Indices in Clinical Variants of Early-Onset Alzheimer Disease.
Granadillo E; Paholpak P; Mendez MF; Teng E
Dement Geriatr Cogn Disord; 2017; 44(1-2):45-54. PubMed ID: 28675901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
